Royalty Report: Medical, Device, Ophthalmological – Collection: 26503


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Medical
  • Device
  • Ophthalmological
  • Surgical

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 26503

License Grant
Pursuant to the License Agreement, the Company granted a license to certain patents owned or licensed by the Company in the field of presbyopia and certain ophthalmology patents.
License Property
Presbyopia is a condition affecting nearly every individual over 40 in which there is a decline in unaided near-distance sight.
Field of Use
Presbyopia Field of Use shall mean laser treatment of presbyopia, including any inherent and/or coincident, related procedures and benefits.

Ophthalmology Field of Use shall mean the medical specialty encompassing the anatomy, functions, pathology and treatment of the eye.

IPSCIO Record ID: 26669

License Grant
A former employee and director of the Company is entitled to revenues from sales of presbyopia products covered by current patents and patents applications he has assigned to the Company.
License Property
Our target market is refractive surgery, particularly for correction of presbyopia, one of the last frontiers of ophthalmology. We believe our new method of laser presbyopia reversal (LAPR) using a laser for surgical correction, is less complicated, more stable, and may provide less regression than mechanical, non-laser methods. We own 16 patents, along with 17 pending patent applications pertaining to presbyopia reversal. We have also submitted two Patent Corporation Treaties for international patents.

IPSCIO Record ID: 26782

License Grant
The U.S. Licensor hereby grants to Swiss Licensee an exclusive license under the Patent Rights, Know How and Trademarks, to make, have made, use, and sell Products in the Territory.
License Property
'PRODUCTS' shall mean ophthalmic medical devices used in the treatment of presbyopia, hyperopia, ocular hypertension and glaucoma, the manufacture, use or sale of which, would, but for this Agreement, constitute or would result in an infringement of the Patent Rights in any country including, but not limited to, the products set forth in the attached SCHEDULE B and any enhancements or improvements thereto.

Licensor's primary products are the patented PresVIEW device and the related PresVIEW Incision System, the automated surgical instrument for the surgical treatment of Presbyopia, Ocular Hypertension and Primary Open Angle Glaucoma, or POA Glaucoma, in the human eye.

The PresVIEW device consists of four separate tiny plastic segments, each about the size of a grain of rice, made from polymethylacrylate, or PMMA. PMMA has been implanted in the eye for other types of surgical procedures (intraocular lenses, hard contact lenses) for over fifty years. The surgeon uses the PresVIEW Incision System to make four superficial incisions in the quadrants of the sclera (white of the eye). The PresVIEW device is inserted into the superficial tunnels, causing a lift in the sclera that in turn reduces the crowding of the underlying muscles.

The full royalty rate schedule has not been made public, the only publicly available rate is a know-how royalty rate for countries where a relevant patent has expired.

Field of Use
The rights granted apply to the human eye.

IPSCIO Record ID: 26792

License Grant
The Licensee is a leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin afflictions in dermatology also referred to as aesthetics.  The Licensee is obligated to pay royalties on sales on certain products under certain license agreements.
Field of Use
The rights granted apply to the healthcare industry.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.